BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 1998
View Archived Issues
DNA immunization against rabies effectively protects nonhuman primates
Read More
Alpha-Beta Technology: Q2 1998 highlights
Read More
Orion: six-month highlights
Read More
Late-stage clinical trials of Oralin to begin in Canada
Read More
Canadian launch for minimally invasive impotence treatment
Read More
Phase II trial commences of AG-3340 in AMD
Read More
Inhibitors of telomerase focus of investigation at CRC Technology, U. Texas
Read More
Japanese and Dutch scientists design LTD4 and dual LTD4/H1 antagonists
Read More
Amersham Pharmacia Biotech completes tender offer for Molecular Dynamics
Read More
Selective 5-HT2C antagonist selected for development at Organon
Read More
SuperGen expands phase III trials of RFS-2000 in pancreatic cancer
Read More
Russian scientists identify GABA analogue with hypotensive activity
Read More
Astra Arcus develops first full, selective alpha7 nAChR agonist
Read More
Glaxo Wellcome studies lamotrigine analogues in the search for new anticonvulsants
Read More
Organon discovers new pharmacophore providing potent, orally active thrombin inhibitors
Read More
Novo files for U.S. marketing approval of insulin analogue
Read More
First group 1 mGluR antagonist with submicromolar potency described by Lilly
Read More
GW-273227, a sodium channel blocker for the treatment of pain
Read More
Advisory committee unanimously recommends approval for Enbrel
Read More
Nasal calcitonin reduces spinal fractures in postmenopausal women with osteoporosis
Read More
Medical device for rheumatoid arthritis scheduled for October advisory panel review
Read More
New treatment for BPH discovered by Hungarian research team
Read More
Famciclovir effectively suppresses recurrent genital herpes
Read More
Baxter refocuses blood substitute program
Read More
IND filed for new insomnia drug candidate from Neurogen and Pfizer
Read More
Neurogen epilepsy drug candidate undergoes further preclinical trials
Read More
La Jolla identifies target of antibodies responsible for life-threatening autoimmune disorder
Read More
Sanofi/BMS antiplatelet agent introduced in U.K.
Read More
